ResMed RMD Cash Flow Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| $398.73M+9.2% | $392.59M+13.9% | $348.54M+11.9% | $379.71M+29.9% | $365.04M+21.5% | ||
| $58.98M+35.0% | $49.89M+7.4% | $47.7M+6.6% | $63.63M+45.7% | $43.68M+0.5% | ||
| $26.79M+11.1% | $28.94M+27.9% | $21.16M+5.0% | $24.75M+15.7% | $24.12M+18.0% | ||
| $16.86M-57.9% | $72.68M+7.1% | -$29.97M+17.7% | $5.22M-90.9% | $40.03M-29.1% | ||
| -$12.48M— | -$26.13M-442% | $14.66M-79.1% | $32.13M+461% | —— | ||
| $103.88M+64.6% | $10.65M+152% | $7.64M+130% | $49.09M-59.8% | $63.09M+77.8% | ||
| $48.34M+161% | $106.39M+144% | -$2.31M-1,980% | -$47.02M-390% | -$79.36M-425% | ||
| -$10.13M-79.4% | —— | -$6.19M-810% | -$2.53M+83.6% | -$5.65M-141% | ||
| $10.05M+22.1% | $12.45M+31.5% | $9.97M+11.0% | $10.66M-3.8% | $8.24M-26.3% | ||
| —— | —— | —— | $911K+297% | $911K+297% | ||
| $554.13M-4.2% | $339.75M+10.1% | $457.32M+40.5% | $538.77M+22.4% | $578.66M+43.9% | ||
| $33.65M+61.8% | $28.54M+38.2% | $42.97M+141% | $30.59M+22.9% | $20.8M-1.9% | ||
| $24.88M— | —— | $522K— | $138.58M+604% | $0-100% | ||
| $20.13M+881% | $4.23M+323% | $2.17M+61.0% | $2.01M-34.5% | $2.05M-14.0% | ||
| $2.5M— | $250K0.0% | $0-100% | $250K-66.7% | $0— | ||
| —— | —— | $2.81M+59.3% | $10.78M+647% | $0-100% | ||
| -$58.03M-82.6% | -$50.94M-38.8% | -$52.58M-2,550% | -$133.71M-187% | -$31.79M+4.1% | ||
| $87.24M+12.3% | $87.58M+12.7% | $87.75M+12.7% | $77.59M+10.0% | $77.7M+10.2% | ||
| $175.01M+133% | $175.01M+133% | $150.01M+200% | $100.01M+100% | $75.03M+50.1% | ||
| —— | $5M0.0% | $0-100% | $5M-98.3% | $0-100% | ||
| $7.43M-17.7% | $29.56M+10.0% | $8.21M-2.1% | $30.16M+8.9% | $9.02M+84.4% | ||
| $418K+14.8% | $20.31M+21.4% | $719K+84.8% | $590K+40.1% | $364K+15.9% | ||
| -$255.24M-77.2% | -$258.35M-75.1% | -$230.27M-52.7% | -$163.89M+58.3% | -$144.07M+57.1% | ||
| $2.58M-67.6% | $2.77M+110% | -$71K-101% | $35.57M— | $7.96M+250% | ||
| $243.44M-40.7% | $33.22M-65.2% | $174.4M-7.2% | $276.74M+61,261% | $410.77M+1,385% | ||
| $6.53M-54.1% | $6.61M— | $6.85M-6.8% | $6.91M+16.7% | $14.22M+29.0% | ||
| $71.67M— | $147.55M+24.4% | $61.87M-41.5% | $16.18M-62.5% | —— | ||
| -$10.13M-79.4% | —— | -$6.19M-810% | -$2.53M+83.6% | -$5.65M-141% | ||
| $1.72M+413% | $1.52M+40.7% | $1.49M+54.6% | $1.27M— | $335K-23.9% | ||
| —— | —— | —— | $911K+297% | $911K+297% | ||
| $48.34M+161% | $106.39M+144% | -$2.31M-1,980% | -$47.02M-390% | -$79.36M-425% | ||
| —— | —— | —— | $0— | $0— | ||
| $10.05M+22.1% | $12.45M+31.5% | $9.97M+11.0% | $10.66M-3.8% | $8.24M-26.3% | ||
| $5.94M+98.4% | —— | —— | —— | $2.99M— | ||
| -$24.07M— | $12.41M— | $4.1M+122% | -$40.41M— | —— | ||
| $24.88M— | —— | $522K-38.9% | $138.58M+604% | $0-100% | ||
| —— | —— | $2.81M+59.3% | $10.78M+647% | $0-100% | ||
| $2.5M— | $250K0.0% | $0-100% | $250K-66.7% | $0— | ||
| —— | —— | —— | $2.71M— | $2.71M— | ||
| $0— | $0— | $0-100% | —— | —— | ||
| —— | —— | —— | $0-100% | $0-100% | ||
| -$3.17M— | $0-100% | $0-100% | —— | —— | ||
| —— | —— | —— | $670K+334% | $0+100% | ||
| $18.94M— | —— | $1.32M— | $101.32M+600% | $0— | ||
| $71.67M— | $147.55M+24.4% | $61.87M-41.5% | $16.18M-62.5% | —— | ||
| $15.61M— | —— | -$798K— | $43.53M+479% | $0— | ||
| $520.48M-6.7% | $311.21M+8.1% | $414.36M+34.7% | $508.18M+22.4% | $557.87M+46.5% | ||
| $520.48M-6.7% | $311.21M+8.1% | $414.36M+34.7% | $508.18M+22.4% | $557.87M+46.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does ResMed generate?
- ResMed (RMD) generated $1.9B in operating cash flow over the trailing twelve months.
- What is ResMed's free cash flow?
- After $135.7M of capital expenditures, ResMed's free cash flow was $1.8B over the trailing twelve months, up 11.8% year over year.
- Where does ResMed's cash flow data come from?
- Every line is extracted from ResMed's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
